106 related articles for article (PubMed ID: 20735479)
1. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
Nagachar N; Ratledge C
FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
[TBL] [Abstract][Full Text] [Related]
2. Roles of trpE2, entC and entD in salicylic acid biosynthesis in Mycobacterium smegmatis.
Nagachar N; Ratledge C
FEMS Microbiol Lett; 2010 Jul; 308(2):159-65. PubMed ID: 20487026
[TBL] [Abstract][Full Text] [Related]
3. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of a role for salicylic acid in iron metabolism of Mycobacterium smegmatis.
Adilakshmi T; Ayling PD; Ratledge C
J Bacteriol; 2000 Jan; 182(2):264-71. PubMed ID: 10629169
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
Perdigão J; Macedo R; Ribeiro A; Brum L; Portugal I
Int J Antimicrob Agents; 2009 Apr; 33(4):334-8. PubMed ID: 19097862
[TBL] [Abstract][Full Text] [Related]
6. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the promoter region of methionine transporter gene
Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
[TBL] [Abstract][Full Text] [Related]
10. The effect of p-aminosalicyclic acid on iron transport and assimilation in mycobacteria.
Brown KA; Ratledge C
Biochim Biophys Acta; 1975 Apr; 385(2):207-20. PubMed ID: 1092357
[TBL] [Abstract][Full Text] [Related]
11. The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways.
Wang R; Marcotte EM
J Proteome Res; 2008 Mar; 7(3):855-65. PubMed ID: 18275136
[TBL] [Abstract][Full Text] [Related]
12. Methionine Antagonizes
Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
[No Abstract] [Full Text] [Related]
13. Inhibition of mycobacterial growth by plumbagin derivatives.
Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
[TBL] [Abstract][Full Text] [Related]
14. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
15. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
16. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.
Li H; Cowie A; Johnson JA; Webster D; Martyniuk CJ; Gray CA
BMC Genomics; 2016 Aug; 17(1):621. PubMed ID: 27514659
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
18. Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis.
McNeil MB; Dennison D; Parish T
Microbiology (Reading); 2017 Jul; 163(7):1065-1070. PubMed ID: 28703701
[TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
20. Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents.
Patole J; Shingnapurkar D; Padhye S; Ratledge C
Bioorg Med Chem Lett; 2006 Mar; 16(6):1514-7. PubMed ID: 16413184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
